Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose intravenous dexamethasone and hypothalamic-pituitary-adrenal axis suppression in healthy volunteers
ACTRN12611001067965Phase 4Completed
- Sponsor
- Dr Marianne Elston
- Start
- Oct 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Dr Marianne Elston. Primary endpoint: Percent cortisol suppression. Started Oct 2011; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ACTRN12611001067965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001067965.